Select the option that best describes what you are looking for
Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.
Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.
Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.
Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.
Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.
Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.
Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.
Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.
Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.
Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.
Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.
Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.
Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.
Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.
Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.
Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.
Certified CRO services with NanoString GeoMx Digital Spatial Profiling.
De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.
Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.
Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.
Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.
Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.
Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.
Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.
Learn more about how our consulting services can help to support your journey to the clinic.
Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.
Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.
We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.
We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.
Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.
Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.
Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.
Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.
Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.
Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.
Melanoma is the least common, yet most deadly form of skin cancer and requires predictive research models such as patient-derived xenografts (PDX) for preclinical evaluation of new cancer treatments. PDX models maintain a true representation of human heterogeneity and provide the most accurate approach to predicting an agent’s efficacy prior to entering the clinic. The Crown Bioscience melanoma PDX collection contains over 200 models including metastatic and primary disease models with clinically relevant mutations e.g. BRAF(V600E). More
PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBER | CANCER TYPE | CANCER SUBTYPE | DESCRIPTION | # per page |
---|---|---|---|---|
ME1154 | Melanoma | NA | Metastatic malignant melanoma of left inguinal LN | CLICK TO VIEW |
ME11971 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME11972 | Melanoma | NA | Adeno | CLICK TO VIEW |
ME11982 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME11985 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME11987 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME11994 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME11995 | Melanoma | NA | Mets melanoma | CLICK TO VIEW |
ME12000 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12002 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12003 | Melanoma | NA | Metastatic melanoma | CLICK TO VIEW |
ME12006 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12007 | Melanoma | NA | Recurrent malignant melanoma | CLICK TO VIEW |
ME12009 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12010 | Melanoma | NA | Melanoma, metastatic | CLICK TO VIEW |
ME12011 | Melanoma | NA | Malignant melanoma, metastatic | CLICK TO VIEW |
ME12016 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12019 | Melanoma | NA | Malignant melanoma. Pathol comment: THE TISSUE CONTAINS 90% TUMOR C/W REFERRING DIAGNOSIS. 10% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12024 | Melanoma | NA | Metastatic Melanoma. Pathol comment: THE TISSUE CONTAINS 90% TUMOR C/W REFERRING DIAGNOSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12026 | Melanoma | NA | Infiltrating malignant neoplasm, C/W MELANOMA. Pathol commnet: THE TISSUE CONTAINS 80% TUMOR C/W REFERRING DIAGNOSIS. 50% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12028 | Melanoma | NA | Melanoma. Pathol comment: THE TISSUE CONTAINS 80% TUMOR C/W REFERRING DIAGNOSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12030 | Melanoma | NA | Melanoma. Pathol comment: TUMOR CELLS PRESENT IN CELL BLOCK AND IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12032 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12033 | Melanoma | NA | Melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12035 | Melanoma | NA | Malignant melanoma. Pathol comment:APPROXIMATELY 50% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12037 | Melanoma | NA | Melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12038 | Melanoma | NA | Malignant melanoma. | CLICK TO VIEW |
ME12039 | Melanoma | ADC | N/A | CLICK TO VIEW |
ME12041 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. | CLICK TO VIEW |
ME12042 | Melanoma | NA | Metastatic Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12043 | Melanoma | NA | Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12044 | Melanoma | NA | Metastatic Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12045 | Melanoma | NA | Melanoma.Pathol comment: APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12046 | Melanoma | NA | Metastatic Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12047 | Melanoma | NA | Metastatic Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12049 | Melanoma | NA | Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12050 | Melanoma | NA | Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12051 | Melanoma | NA | Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12052 | Melanoma | NA | Melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12053 | Melanoma | NA | Metastatic Malignant Melanoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12054 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12055 | Melanoma | NA | Melanoma. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12056 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12057 | Melanoma | NA | Malignant melanoma. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12059 | Melanoma | NA | Melanoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12060 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12061 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12062 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN SECTIONS EXAMINED AND CYTOSPIN PREP. | CLICK TO VIEW |
ME12064 | Melanoma | NA | Malignant melanoma. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12065 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12067 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12068 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12069 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12070 | Melanoma | NA | Melanoma.Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12071 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12075 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12076 | Melanoma | NA | Recurrent Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12077 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12078 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12079 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12080 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12081 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 95% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12084 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12085 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12086 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12088 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12091 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12093 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12094 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12095 | Melanoma | NA | Melignant Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12096 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12098 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12099 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12100 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12101 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12102 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12103 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12104 | Melanoma | NA | Melanoma STAGE III. Pathol comment: APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12105 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 75% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12106 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12107 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. | CLICK TO VIEW |
ME12108 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12109 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12111 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12113 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12114 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12115 | Melanoma | NA | Melignant Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12116 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12117 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12119 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12120 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12122 | Melanoma | N/A | N/A | CLICK TO VIEW |
ME12125 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12126 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12127 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12128 | Melanoma | NA | Recurrent Melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12129 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12130 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12131 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12132 | Melanoma | NA | Melanoma.Pathol comment: C/W CLINICAL DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN. | CLICK TO VIEW |
ME12133 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 95% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12134 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12135 | Melanoma | NA | metastatic melanoma. Pathol comments: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. | CLICK TO VIEW |
ME12136 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12137 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12138 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12139 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12141 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12142 | Melanoma | NA | Metastatic Melanoma. C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12143 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12144 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12145 | Melanoma | NA | Melanoma.Pathol comment: NO VIABLE TUMOR CELLS PRESENT IN SECTIONS EXAMINED. 100% NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12147 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12148 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12149 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12150 | Melanoma | NA | Recurrent Metastatic Melanoma. C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12151 | Melanoma | melanoma (sent as lymphoma) | N/A | CLICK TO VIEW |
ME12153 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12154 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROX. 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12155 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROX. 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12156 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12159 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12160 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12163 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12164 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12165 | Melanoma | NA | Malignant melanoma, stage IV.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12166 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. | CLICK TO VIEW |
ME12167 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN TISSUE SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12168 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12170 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12171 | Melanoma | NA | metastatic malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 5% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12172 | Melanoma | NA | Melanoma. Pathol commnet: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12173 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12175 | Melanoma | NA | Metastatic malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12177 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME12178 | Melanoma | NA | Malignant melanoma. Metastatic melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. APPROXIMATELY 5% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12179 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 40% NECROSIS. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12180 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12181 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12182 | Melanoma | NA | Metastatic malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12183 | Melanoma | NA | Vaginal melanoma. Metastatic melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12184 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12185 | Melanoma | NA | Malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 30% NECROSIS. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME12207 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12208 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12209 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12211 | Melanoma | NA | Metastatic melanoma | CLICK TO VIEW |
ME12212 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12213 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12214 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12215 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12216 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12217 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12218 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12219 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12220 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12221 | Melanoma | NA | Malignant melanoma | CLICK TO VIEW |
ME12222 | Melanoma | NA | Malignant melanoma. Metastatic melanoma. | CLICK TO VIEW |
ME12223 | Melanoma | NA | melanoma | CLICK TO VIEW |
ME12224 | Melanoma | NA | Melanoma metastatic to stomach | CLICK TO VIEW |
ME13974 | Melanoma | NA | Malignant Melanoma | CLICK TO VIEW |
ME13982 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13983 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 30% OF TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13984 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 80% OF TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13986 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13989 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13991 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. | CLICK TO VIEW |
ME13993 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13994 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13995 | Melanoma | NA | Melanoma.Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME13996 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14000 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14001 | Melanoma | NA | Metastatic Melanoma. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14002 | Melanoma | NEC | Melanoma, Malignant melanocytic neoplasm favor malignant melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14003 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14004 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14005 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 20% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14006 | Melanoma | NA | Malignant metastatic melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14007 | Melanoma | NA | Metastatic melanoma.Pathol comment: NO MALIGNANT TUMOR CELLS IN TISSUE SECTIONS EXAMINED. RARE MELANOMA CELLS PRESENT WITH EXTENSIVE NECROSIS IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14008 | Melanoma | NA | Metastatic Melanoma.Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 20% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14009 | Melanoma | NA | Melanoma.Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14010 | Melanoma | NA | Melanoma.Pathol comment: NO MALIGNANT TUMOR CELLS PRESENT IN TISSUE EXAMINED. ABUNDANT MELANIN PIGMENT PRESENT. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
ME14013 | Melanoma | NA | Malignant metastatic melanoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. | CLICK TO VIEW |
ME14017 | Melanoma | NA | Malignant melanoma. Pathol comment : | CLICK TO VIEW |
ME2194 | Melanoma | NA | Malignant melanoma of right nasal cavity. IHC results: CK(-), Vim(+/-), HMB45(+), Mart-1(+/-), S-100(+), P63(-), LCA(-), Des(-), Act(-). | CLICK TO VIEW |
ME2319 | Melanoma | NA | Melanoma | CLICK TO VIEW |
ME2395 | Melanoma | melanoma (sent as lymphoma) | N/A | CLICK TO VIEW |
ME2396 | Melanoma | melanoma (sent as lymphoma) | N/A | CLICK TO VIEW |
ME2489 | Melanoma | NA | Malignant melanoma. Pathol comment: | CLICK TO VIEW |
ME3332 | Melanoma | NA | Malignant melanoma. | CLICK TO VIEW |
ME3608 | Melanoma | NA | Left lower limb: malignant melonoma, postoperative recurrence | CLICK TO VIEW |
ME5273 | Melanoma | Sarcoma | Melanoma.Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5275 | Melanoma | NA | Melanoma.Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5277 | Melanoma | N/A | N/A | CLICK TO VIEW |
ME5279 | Melanoma | NA | Malignant melanoma. Pathol commnet: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5280 | Melanoma | NA | melanoma metastatic melanoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5281 | Melanoma | NA | Melanoma.Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5282 | Melanoma | NA | melanoma metastatic melanoma.Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. | CLICK TO VIEW |
ME5284 | Melanoma | NA | Malignant melanoma. Pathol comment: c/w diagnosis. approximately 95% of the tissue involved by malignant tumor in sections examined. approximately 90% malignant tumor cells present in cytospin preparation. | CLICK TO VIEW |
ME5285 | Melanoma | NA | malignant melanoma metastatic malignant melanoma.Pathol comment: c/w diagnosis. approximately 5% of the tissue involved by viable malignant tumor in sections examined. extensive tumor necrosis. approximately 90% malignant tumor cells present in cytospin preparation. | CLICK TO VIEW |
ME5286 | Melanoma | NA | malignant melanoma metastatic melanoma. | CLICK TO VIEW |
ME6928 | Melanoma | Malignant melanoma | NA | CLICK TO VIEW |
ME9364 | Melanoma | melanoma (sent as lymphoma) | N/A | CLICK TO VIEW |
ME9366 | Melanoma | NA | NA | CLICK TO VIEW |
ME9370 | Melanoma | Malignant melanoma | NA | CLICK TO VIEW |
ME9374 | Melanoma | Malignant melanoma | NA | CLICK TO VIEW |
ME9382 | Melanoma | Malignant melanoma | NA | CLICK TO VIEW |
ME9389 | Melanoma | melanoma (sent as lymphoma) | N/A | CLICK TO VIEW |
ME9392 | Melanoma | Malignant melanoma | NA | CLICK TO VIEW |
ME9393 | Melanoma | melanoma (sent as lymphoma) | NA | CLICK TO VIEW |
ME9394 | Melanoma | melanoma (sent as lymphoma) | NA | CLICK TO VIEW |
ME9395 | Melanoma | melanoma (sent as lymphoma) | NA | CLICK TO VIEW |
Already Registered? Login
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy